Group pushing for generic version of remdesivir drug to treat Covid-19 patients

By LOH FOON FONG

Gilead Sciences Inc pharmaceutical company - Filepic

KUALA LUMPUR: A group of more than 50 health-related organisations and individuals is urging American biopharmaceutical company Gilead Sciences to allow Malaysia to import generic versions of remdesivir, an anti-viral drug used to treat Covid-19 patients.

The generic versions of remdesivir, which was originally developed to treat Ebola, are from manufacturers Gilead has given voluntary licensing (VL) agreements to.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Gilead Sciences , Covid-19 , Coronavirus , Remdesivir , Voluntary licensing agreements , Drug

Next In Nation
Sg Petani cops detain man who threatened neighbour with gun
Jaywalker hit by motorbike while chatting with lorry driver on JB road
Thirty motorcycles seized during anti-street racing crackdown in Ipoh
Developers urged to reduce parking spaces for new projects near public transport stations
Immigration detains 139 foreigners in KL anti-vice raids
MetMalaysia issues two-day continuous rain alert for Johor and Sarawak
Malaysia seeks deeper tourism ties with Bangladesh, says envoy
Rafizi alleges MACC detained PKR members not aligned to top leadership in lead-up to party polls
Allocation for tax refunds increased to RM4bil to expedite payments to taxpayers
Anwar launches enhanced insurance scheme for low-income households

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.